Status:
COMPLETED
Tumor Registry of Lymphatic Neoplasia
Lead Sponsor:
iOMEDICO AG
Conditions:
Non-Hodgkin's Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry is to record information on therapy reality of malignant lymphatic systemic diseases by office-based haematologists in Germany.
Detailed Description
The TLN is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of lymphatic neoplasms in Germany. The registry will follow pati...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Non-Hodgkin's lymphoma, chronic lymphocytic leukaemia or multiple myeloma
- Must receive a first- or second-line therapy
- 18 years or older
- Signed, written informed consent
Exclusion
- \- no systemic therapy
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
3795 Patients enrolled
Trial Details
Trial ID
NCT00889798
Start Date
April 1 2009
End Date
August 31 2019
Last Update
May 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.